Search

These data provide evidence that otitis-prone children do not have impaired functional cell mediated immunity

This Clinical Puzzle article describes our current knowledge of chronic otitis media and the existing research models for this condition

The production of functional antipneumococcal antibodies in otitisprone children demonstrates that they respond to the current pneumococcal conjugate vaccine (PCV)and are likely to respond to pneumolysin-based vaccines as effectively as healthy children.

Our findings are in line with a number of epidemiological studies which show a positive association between breastfeeding and OM in early childhood

Conserved vaccine candidate proteins from S.pneumoniae induce serum and salivary antibody responses in Aboriginal and non-Aboriginal children with history of OM

Identified dominant PCR-ribotypes common to geographically disparate Australian paediatric populations

Otitis media (OM) starts within weeks of birth in almost all Indigenous infants living in remote areas of the Northern Territory (NT).

Consumers and community members are invited to join us to provide input into our childhood infectious diseases research.

The introduction of universal newborn hearing screening has allowed for early identification and diagnosis of children with severe-profound hearing loss. This study aims to provide the first Western Australian perspective on the surgical feasibility and safety of cochlear implantation before 12 months of age.

Chronic suppurative otitis media (CSOM), sometimes referred to as chronic otitis media, is a chronic inflammation and often polymicrobial infection (involving more than one micro-organism) of the middle ear and mastoid cavity, characterised by ear discharge (otorrhoea) through a perforated tympanic membrane.